|1.||Canis, Michel: 8 articles (06/2012 - 04/2007)|
|2.||Matsuzaki, Sachiko: 8 articles (06/2012 - 04/2007)|
|3.||Henry, Gerard D: 7 articles (05/2015 - 01/2005)|
|4.||Mage, Gérard: 7 articles (05/2011 - 04/2007)|
|5.||Wilson, Steven K: 6 articles (06/2012 - 01/2005)|
|6.||Carson, Culley C: 5 articles (01/2015 - 01/2005)|
|7.||Wang, Run: 4 articles (05/2015 - 07/2009)|
|8.||Garber, Bruce B: 4 articles (01/2015 - 03/2012)|
|9.||Mönkkönen, Jukka: 4 articles (11/2012 - 10/2009)|
|10.||Bazin, Jean-Etienne: 4 articles (11/2010 - 04/2007)|
04/01/1997 - "Early results suggest that outpatient IPP insertion is a safe, effective treatment for men with organic impotence."
05/01/2015 - "After IRB approval, we conducted a prospective, three-center study of 40 patients who underwent IPP placement, with NLMT for end organ failure erectile dysfunction with the Coloplast Titan IPP. "
11/01/2012 - "Patients with erectile dysfunction scheduled for IPP implantation were approached for study participation. "
01/01/2015 - "We herein report an unusual complication of penile hydrocele formation that developed following placement of an IPP for erectile dysfunction. "
10/01/2014 - "We retrospectively reviewed a consecutive series of 550 patients with refractory organic erectile dysfunction who were implanted with a Coloplast Titan IPP with the OTR pump during a period of approximately 4 years. "
|2.||Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/01/2013 - "The aim of this study was to identify whether intravesical prostatic protrusion (IPP) is related to the characteristics of voiding symptoms improvement after drug treatment in benign prostatic hyperplasia patients. "
12/01/2012 - "To evaluate whether intravesical protrusion of the prostate (IPP) is related to the treatment effect of alpha-1 receptor antagonist in patients with lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) with a prostate size of less than 40 g. "
07/01/2012 - "BWT was correlated with IPP, the storage symptom subscore, and the responsiveness of storage symptoms to alpha-blockers in LUTS/benign prostatic hyperplasia (BPH) patients. "
07/01/2012 - "To evaluate the significance of intravesical prostatic protrusion (IPP) for predicting postoperative outcomes in patients with benign prostatic hyperplasia. "
04/01/2012 - "The aim of this research was to assess the value of the transitional zone index (TZI) and intravesical prostatic protrusion (IPP) from transrectal ultrasonography in evaluating the severity and progression of disease by analyzing the relationship between the 2 parameters and symptoms, clinical history, and urodynamics in benign prostatic hyperplasia (BPH) patients undergoing different treatment. "
|3.||Breast Neoplasms (Breast Cancer)
03/01/2010 - "In conclusion, these results suggest that the novel PP-DHA and IPP-DHA conjugates and their amide derivatives may be useful for the treatment of breast cancer."
07/01/2011 - "In this study, we investigated the correlation between the anticancer activities of Vγ9Vδ2 T cells and the intracellular IPP/ApppI levels in ZOL-treated breast cancer cells in vitro and in vivo. "
02/01/2015 - "Further, human breast cancer cells have been shown to differ remarkably in their ZOL treatment induced IPP/ApppI production and responses to that. "
02/01/2015 - "Cytotoxic Vγ9Vδ2 T cells have been shown to recognize IPP/ApppI in breast cancer cells. "
04/01/2012 - "The expression of TSHR, IPP, and OCT4 increased in the human breast tumor samples over the noncancer tissues. "
|4.||Alzheimer Disease (Alzheimer's Disease)
02/01/2011 - "The study aims to assess the efficacy of the Big Brain Academy (BBA), a computerized cognitive training program (CT) based on video games, compared to the Integrated Psychostimulation Program (IPP), a classical CT tool for patients with Alzheimer's disease (AD). "
10/01/2006 - "Although both the IPP and IMIS improved cognition in patients with Alzheimer's disease, the IMIS program provided an improvement above and beyond that seen with IPP alone, which lasted for 24 weeks."
04/01/2014 - "A randomized study is currently underway to compare IPP to standard treatment in patients with unresectable recurrent pelvic tumors of gynecological or gastrointestinal origin. "
12/01/2009 - "The present study was undertaken to clarify whether IPP and/or ApppI has a direct involvement in apoptosis caused by ZOL in different cancer cell lines. "
11/15/2012 - "However, mechanisms responsible for Vγ9Vδ2 T-cell recognition of N-BP-treated tumors producing IPP/ApppI remain unclear. "
07/01/2011 - "Moreover, IPP/ApppI not only accumulated in cancer cells but it was also secreted, promoting Vγ9Vδ2 T-cell chemotaxis to the tumor. "
07/01/2011 - "IPP/ApppI accumulation in ZOL-treated cancer cells may be recognized by Vγ9Vδ2 T cells as tumor phosphoantigens in vitro. "
|1.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|8.||spliceosomal peptide P140
|1.||Penile Prosthesis (Penile Implants)
|3.||Nerve Block (Nerve Blocks)
|5.||Artificial Urinary Sphincter